dihydroxyphenylalanine has been researched along with Brain Damage, Chronic in 3 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TURNER, WJ | 1 |
| MERLIS, S | 1 |
| Ribasés, M | 1 |
| Serrano, M | 1 |
| Fernández-Alvarez, E | 1 |
| Pahisa, S | 1 |
| Ormazabal, A | 1 |
| García-Cazorla, A | 1 |
| Pérez-Dueñas, B | 1 |
| Campistol, J | 1 |
| Artuch, R | 1 |
| Cormand, B | 1 |
| Wender, PH | 1 |
3 other studies available for dihydroxyphenylalanine and Brain Damage, Chronic
| Article | Year |
|---|---|
A CLINICAL TRIAL OF PARGYLINE AND DOPA IN PSYCHOTIC SUBJECTS.
Topics: Adolescent; Biomedical Research; Brain; Brain Damage, Chronic; Depression; Depressive Disorder, Majo | 1964 |
A homozygous tyrosine hydroxylase gene promoter mutation in a patient with dopa-responsive encephalopathy: clinical, biochemical and genetic analysis.
Topics: Brain Damage, Chronic; Child; Child, Preschool; Cyclic AMP; Dihydroxyphenylalanine; Dopamine Agents; | 2007 |
The minimal brain dysfunction syndrome in children. I. The syndrome and its relevance for psychiatry. II. A psychological and biochemical model for the syndrome.
Topics: Affect; Amphetamine; Arousal; Attention Deficit Disorder with Hyperactivity; Autonomic Nervous Syste | 1972 |